Is pomegranate a useful treatment for Alzheimer's?
Dietary therapies such as pomegranate consumption are being studied for Alzheimer's disease, a neurological condition that progresses over time. According to a recent study, urilinium A helps treat the condition by clearing the brain of damaged mitochondria.
Alzheimer's disease is a neurological illness that progresses over time and causes memory loss, cognitive decline, and finally the inability to perform daily tasks. Although there isn't a solution for the condition yet, researchers are looking into several dietary strategies that could be able to stop or lessen its effects.
Pomegranate eating is one such intervention; this fruit is well-known for its strong antioxidant content and several health advantages.
Urolithin A's potential use in the treatment of Alzheimer's disease is shown by a new study.
UA is a naturally occurring substance that is created when gut bacteria consume ellagitannins and ellagic acid, a polyphenol that can be found in nuts, berries, and pomegranates. Researchers at the University of Copenhagen conducted a recent study to examine the potential therapeutic benefits of urolithin A. Utilizing mice models for the research, it was shown that urolithin A was essential in clearing the brain's damaged mitochondria.
A substance called urolithin A is obtained from ellagitannins, which are produced by gut bacteria and present in some meals. Ellagitannin-rich foods include pecans, walnuts, strawberries, raspberries, and pomegranates. After being ingested, these foods are converted by microbes in the digestive tract to urolithin A, which has been linked to a number of possible health advantages, including enhancing muscular and mitochondrial function.
What's Your Reaction?
